How to control ESR and CRP In admit patient
CRP ESR elevated inpatient management inflammatory markers
| Category | Examples | Key Workup |
|---|---|---|
| Infection | Bacterial (sepsis, pneumonia, UTI, endocarditis, osteomyelitis, epidural abscess) | Blood cultures, urine culture, CXR, procalcitonin, WBC differential |
| Autoimmune / Rheumatologic | RA, SLE, vasculitis, polymyalgia rheumatica, IBD | ANA, RF, ACPA, ANCA, complement levels |
| Malignancy | Lymphoma, solid tumors | LDH, peripheral smear, imaging |
| Tissue injury | Post-surgery, MI, trauma | History, troponin, ECG |
| Other | Pregnancy, obesity, advanced age, anemia, paraproteinemia | CBC, protein electrophoresis |
Clinical tip: A low CRP but high ESR should raise suspicion for paraproteinemia (e.g., multiple myeloma). In active SLE, CRP is often paradoxically normal or only mildly elevated - don't rely on it. A CRP >10 mg/dL is more concerning for bacterial infection or systemic vasculitis than for typical autoimmune flares. (Harriet Lane Handbook; Goldman-Cecil)
| Marker | How Quickly Falls | Best Use |
|---|---|---|
| CRP | Days (half-life 5-7 hours) | Best for real-time monitoring of treatment response |
| ESR | Weeks to months | Better for long-term monitoring (e.g., GCA, TB) |
Important note: This guide covers general principles. Specific management depends on the confirmed diagnosis. If the cause of elevated ESR/CRP is not clear in your admitted patient, rheumatology, infectious disease, or hematology input may be needed.
Medicine for high CRP
CRP reduction anti-inflammatory therapy inpatient
Examples: Co-amoxiclav, piperacillin-tazobactam, meropenem, vancomycin - based on organism and site.
| Drug | Typical Adult Dose | Notes |
|---|---|---|
| Ibuprofen | 400-600 mg TDS with food | First-line for pericarditis, mild RA, gout |
| Naproxen | 500 mg BD | Longer acting, good for arthritis |
| Indomethacin | 25-50 mg TDS | Potent; use in acute gout, pericarditis |
| Aspirin (high dose) | 650-900 mg every 4-6 hours | Used in pericarditis specifically |
| Drug | Route | Typical Dose | When to Use |
|---|---|---|---|
| Prednisolone | Oral | 0.5-1 mg/kg/day | RA flare, SLE, IBD, vasculitis |
| Methylprednisolone | IV | 1 g/day x 3 days (pulse) | Severe autoimmune flare, ANCA vasculitis |
| Dexamethasone | IV/Oral | 6-8 mg/day | Meningitis, severe inflammation, COVID |
| Hydrocortisone | IV | 100 mg TDS | Septic shock with adrenal insufficiency |
| Drug | Use |
|---|---|
| Tocilizumab (IV/SC) | Rheumatoid arthritis, giant cell arteritis, cytokine release syndrome (CAR-T, severe COVID) |
| Sarilumab (SC) | Rheumatoid arthritis |
| Drug | Condition |
|---|---|
| Methotrexate | RA, psoriatic arthritis |
| Hydroxychloroquine | SLE, mild RA |
| Sulfasalazine | RA, IBD |
| Azathioprine | SLE, IBD, vasculitis |
| Drug | Condition |
|---|---|
| Adalimumab | RA, Crohn's, AS |
| Infliximab | RA, IBD, psoriasis |
| Etanercept | RA, psoriatic arthritis |
| Condition | First-Line Drug for CRP |
|---|---|
| Sepsis / Infection | Antibiotics (source-directed) |
| Acute Gout | Colchicine or NSAID or steroid |
| Pericarditis | Aspirin or NSAID + Colchicine |
| RA flare | NSAID + Steroid (short course); long-term: DMARDs |
| SLE flare | Hydroxychloroquine + Prednisolone |
| Giant cell arteritis | High-dose Prednisolone (40-60 mg/day) ± Tocilizumab |
| Cytokine storm / CAR-T | Tocilizumab (most effective) |
| IBD flare | Steroids ± biologics |
| Post-surgical (normal rise) | Nothing needed - CRP peaks Day 2, falls by Day 4 |
| Persistently elevated with no clear cause | Investigate for occult malignancy / TB / chronic infection |
| Intervention | Effect on CRP |
|---|---|
| Statins (e.g., rosuvastatin, atorvastatin) | Reduce CRP independently of cholesterol (pleiotropic anti-inflammatory effect) - used in cardiovascular risk |
| Omega-3 fatty acids | Mild anti-inflammatory; relevant for chronic low-grade elevation |
| Weight loss | Obesity chronically elevates CRP; losing weight reduces baseline CRP |
| Smoking cessation | Smoking elevates CRP; cessation reduces it |
Monitor CRP every 48 hours. A falling CRP = treatment is working. A rising or plateauing CRP after appropriate treatment = search for missed diagnosis, undrained focus, resistant organism, or complication.